🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 6

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 6 of 11
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
May 3, 2024 at 12:00 AM#26

Following on from sarah_TO — and this may be the naive question:

Was that from a primary source or from a summary of one?

28 1denise_HTX, raj_cambridge, ingrid_STO and 25 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
May 14, 2024 at 8:59 AM#27
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Last edited: May 14, 2024 at 2:59 PM
29 2FranDenver, Dr.BariatricHTX, LindaRN_retired and 26 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
May 25, 2024 at 5:51 PM#28
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Happy to go further on any of that.

30 3Dr.SleepRoch, laura_annarbor, JenMemphis and 27 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Jun 6, 2024 at 2:37 AM#29
Dr.PathRoch said:
One practical note: write down what you did and when, before you need it.

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

31 4DoseLogDan, SleepFixSam, PurityPaulOR and 28 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Jun 17, 2024 at 11:16 AM#30

Reporting back.

Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

3 1Dr.GastroMayo, JakeBK_lifts, DerekSJ_a1c
Reply Quote Save Share Report
14567811

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register